2 Minute Medicine3h
Inebilizumab reduces the risk of flares in IgG4-related disease
In this randomized controlled trial, inebilizumab, an anti-CD19 monoclonal antibody, reduced the risk of flares and increased ...
Neurology Advisor4h
Inebilizumab Improves Generalized Myasthenia Gravis Symptoms in Phase 3 Trial
Treatment with inebilizumab is significantly effective and safe for patients with AChR+ or MuSK+ generalized myasthenia ...